A guide to reducing the risk of 25 G surgery

Article

Dr Richard Kaiser outlines the recommendations of the microsurgical safety task force.

Key Points

The increasing trend towards microincision surgery is evident across several branches of ophthalmology, vitrectomy surgery included. As with most evolutionary routes, the transition to minimally invasive vitrectomy surgery (MIVS) has not been a smooth one, with new techniques and instruments enjoying their fair share of bad press in recent years.

Endophthalmitis risk too high to ignore

Having read similar reports elsewhere, Dr Kaiser set up the Micro-Surgical Safety Task Force, the aim of the team being to develop a set of recommendations to attempt to reduce the seemingly higher rate of endophthalmitis associated with 25 G vitrectomy. "The task force did not intend to come up with the solution to eliminating all risks associated with 25 G surgery but, between the members, there are a lot of years of experience," remarked Dr Kaiser. The team is comprised of 12 experienced retina surgeons, including George Williams, Antonio Capone, Robert Avery, Harry Flynn, and Ingrid Scott.

According to Dr Kaiser, the answer does not lie in the instrumentation; rather, it lies in the surgical technique.

"Before we put together a list of recommendations, we met several times, for hours at a time. We analyzed the technique in great detail to see if we could identify steps that could be improved or altered in order to reduce the risk of endophthalmitis," said Dr Kaiser.

The recommendations

The team developed recommendations. The following are some of the highlights:

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.